CN101550151B - 一种头孢美唑钠化合物的合成方法 - Google Patents
一种头孢美唑钠化合物的合成方法 Download PDFInfo
- Publication number
- CN101550151B CN101550151B CN2009100149725A CN200910014972A CN101550151B CN 101550151 B CN101550151 B CN 101550151B CN 2009100149725 A CN2009100149725 A CN 2009100149725A CN 200910014972 A CN200910014972 A CN 200910014972A CN 101550151 B CN101550151 B CN 101550151B
- Authority
- CN
- China
- Prior art keywords
- cefmetazole
- sodium
- cephem
- beta
- synthetic method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- SNBUBQHDYVFSQF-HIFRSBDPSA-N cefmetazole Chemical compound S([C@@H]1[C@@](C(N1C=1C(O)=O)=O)(NC(=O)CSCC#N)OC)CC=1CSC1=NN=NN1C SNBUBQHDYVFSQF-HIFRSBDPSA-N 0.000 title claims abstract description 27
- 229960002676 cefmetazole sodium Drugs 0.000 title claims abstract description 18
- 238000010189 synthetic method Methods 0.000 title claims abstract description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 24
- 238000006243 chemical reaction Methods 0.000 claims abstract description 18
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229960003585 cefmetazole Drugs 0.000 claims abstract description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 27
- 238000003756 stirring Methods 0.000 claims description 25
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 14
- IVVHVQMLZKNIAI-UHFFFAOYSA-L C(C)(=O)[O-].[Na+].C[S+].N#CC#N.C(C)(=O)[O-] Chemical compound C(C)(=O)[O-].[Na+].C[S+].N#CC#N.C(C)(=O)[O-] IVVHVQMLZKNIAI-UHFFFAOYSA-L 0.000 claims description 11
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 6
- 230000001143 conditioned effect Effects 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 2
- 239000002994 raw material Substances 0.000 abstract description 4
- LPANHMBHYJSFML-UHFFFAOYSA-N [Na].C(#N)CCC(=S)O Chemical compound [Na].C(#N)CCC(=S)O LPANHMBHYJSFML-UHFFFAOYSA-N 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 description 5
- -1 cephalosporin compound Chemical class 0.000 description 4
- 230000002194 synthesizing effect Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 235000015424 sodium Nutrition 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 229930186147 Cephalosporin Natural products 0.000 description 2
- 229940124587 cephalosporin Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 description 1
- 241000606124 Bacteroides fragilis Species 0.000 description 1
- 206010061695 Biliary tract infection Diseases 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- AYDQIZKZTQHYIY-UHFFFAOYSA-N OC(=O)C1(C)CC(C(O)=O)=CC=C1 Chemical compound OC(=O)C1(C)CC(C(O)=O)=CC=C1 AYDQIZKZTQHYIY-UHFFFAOYSA-N 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 241000190932 Rhodopseudomonas Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 206010062255 Soft tissue infection Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002902 bimodal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- JMANVNJQNLATNU-UHFFFAOYSA-N glycolonitrile Natural products N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
Landscapes
- Cephalosporin Compounds (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100149725A CN101550151B (zh) | 2009-05-07 | 2009-05-07 | 一种头孢美唑钠化合物的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100149725A CN101550151B (zh) | 2009-05-07 | 2009-05-07 | 一种头孢美唑钠化合物的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101550151A CN101550151A (zh) | 2009-10-07 |
CN101550151B true CN101550151B (zh) | 2010-12-29 |
Family
ID=41154667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100149725A Expired - Fee Related CN101550151B (zh) | 2009-05-07 | 2009-05-07 | 一种头孢美唑钠化合物的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101550151B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101787039B (zh) * | 2010-01-26 | 2012-05-09 | 陶灵刚 | 一种高纯度的头孢美唑钠化合物 |
CN101787040B (zh) * | 2010-03-02 | 2011-09-07 | 哈药集团制药总厂 | 一种头孢美唑钠的制备方法 |
CN102180892B (zh) * | 2011-03-24 | 2013-03-06 | 海南灵康制药有限公司 | 一种纯化头孢美唑钠的新方法 |
CN102718780A (zh) * | 2011-06-03 | 2012-10-10 | 刘伟娜 | 一种头孢美唑钠的制备方法 |
CN103709179B (zh) * | 2013-12-17 | 2016-03-30 | 福建省福抗药业股份有限公司 | 一种头孢美唑钠的合成及提纯方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0113242A2 (en) * | 1982-12-29 | 1984-07-11 | Kureha Kagaku Kogyo Kabushiki Kaisha | Cephalosporin derivatives |
-
2009
- 2009-05-07 CN CN2009100149725A patent/CN101550151B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0113242A2 (en) * | 1982-12-29 | 1984-07-11 | Kureha Kagaku Kogyo Kabushiki Kaisha | Cephalosporin derivatives |
Also Published As
Publication number | Publication date |
---|---|
CN101550151A (zh) | 2009-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101550151B (zh) | 一种头孢美唑钠化合物的合成方法 | |
CN102391289B (zh) | 头孢他啶中间体及头孢他啶的合成方法 | |
CN101812076B (zh) | 头孢呋辛钠及其制备方法 | |
CN107033161B (zh) | 一种他唑巴坦酸的合成方法 | |
CN101787040B (zh) | 一种头孢美唑钠的制备方法 | |
CN101613361A (zh) | 头孢西丁钠的制备方法 | |
CN103709179B (zh) | 一种头孢美唑钠的合成及提纯方法 | |
CN102219794A (zh) | 一种头孢唑肟钠的制备方法 | |
CN105085544B (zh) | 一种他唑巴坦二苯甲酯的合成方法 | |
CN101696213A (zh) | 甲氧头孢中间体7-mac的合成方法 | |
US20230045135A1 (en) | Tedizolid intermediate and efficient preparation method thereof | |
CN101357927A (zh) | 7-氨基-3-无-3-头孢-4-羧酸的制备方法 | |
CN101735250A (zh) | 一种新路线的头孢替唑钠化合物 | |
CN101671349B (zh) | 一种新路线的头孢呋辛钠化合物 | |
CN101696215B (zh) | 一种五水头孢唑啉钠化合物 | |
CN101633666B (zh) | 一种盐酸头孢替安化合物及其新制法 | |
CN101768171A (zh) | 一种新路线的头孢泊肟酯化合物 | |
CN101550150B (zh) | 一种头孢甲肟化合物及其合成方法 | |
CN104610280B (zh) | 一种头孢噻吩酸的制备方法 | |
CN102911186B (zh) | 一种头孢唑肟钠的制备及精制方法 | |
CN105017285A (zh) | 一种新型头孢类抗感染药物的合成工艺 | |
CN101717324B (zh) | 一种三苯基氯甲烷的绿色合成方法 | |
CN108299471A (zh) | 一种头孢美唑中间体的改进制备工艺 | |
CN106699730A (zh) | 2‑甲基‑5‑(5‑溴吡啶‑2‑基)四氮唑的制备方法 | |
CN102532168A (zh) | 头孢哌酮酸的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HAINAN BENCHUANG PHARMACEUTICAL TECHNOLOGY CO., LT Free format text: FORMER OWNER: ZHANG XIFEN Effective date: 20101228 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 310052 ROOM 1602, BUILDING 3, SHUIYINCHENG, BINSHENG ROAD, BINJIANG DISTRICT, HANGZHOU CITY, ZHEJIANG PROVINCE TO: 570125 ROOM 2601, XINDA BUSINESS BUILDING, NO.48, GUOMAO ROAD, HAIKOU CITY, HAINAN PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20101228 Address after: The new business building No. 48 570125 Hainan city of Haikou province China World Trade Center Road, room 2601 Applicant after: Hainan Benchuang Pharmaceutical Technology Co., Ltd. Address before: 310052, Zhejiang, Hangzhou province Binjiang District foreshore road watermark city 3, room 1602 Applicant before: Zhang Xifen |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Hainan Lingkang Pharmaceutical Co., Ltd. Assignor: Hainan Benchuang Pharmaceutical Technology Co., Ltd. Contract record no.: 2011370000119 Denomination of invention: Cefmetazole sodium compound synthetic method Granted publication date: 20101229 License type: Exclusive License Open date: 20091007 Record date: 20110421 |
|
ASS | Succession or assignment of patent right |
Owner name: HAINAN LINGKANG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: HAINAN BENCHUANG PHARMACEUTICAL TECHNOLOGY CO., LTD. Effective date: 20130729 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 570125 HAIKOU, HAINAN PROVINCE TO: 570216 HAIKOU, HAINAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130729 Address after: 570216 Hainan Province, Haikou city Jinpan Industrial Development Zone Industrial Village No. 3-6 building Patentee after: Hainan Lingkang Pharmaceutical Co., Ltd. Address before: The new business building No. 48 570125 Hainan city of Haikou province China World Trade Center Road, room 2601 Patentee before: Hainan Benchuang Pharmaceutical Technology Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101229 Termination date: 20170507 |
|
CF01 | Termination of patent right due to non-payment of annual fee |